Search results for "BLAST"

showing 10 items of 2136 documents

Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells.

2014

Mutations in the RP2 gene lead to a severe form of X-linked retinitis pigmentosa. RP2 patients frequently present with nonsense mutations and no treatments are currently available to restore RP2 function. In this study, we reprogrammed fibroblasts from an RP2 patient carrying the nonsense mutation c.519C>T (p.R120X) into induced pluripotent stem cells (iPSC), and differentiated these cells into retinal pigment epithelial cells (RPE) to study the mechanisms of disease and test potential therapies. RP2 protein was undetectable in the RP2 R120X patient cells, suggesting a disease mechanism caused by complete lack of RP2 protein. The RP2 patient fibroblasts and iPSC-derived RPE cells showed phe…

MaleNonsense mutationInduced Pluripotent Stem CellsGene ExpressionRetinal Pigment EpitheliumBiologymedicine.disease_causeBioinformaticschemistry.chemical_compoundYoung AdultGTP-Binding ProteinsRetinitis pigmentosaGeneticsmedicineHumansCiliaFibroblastInduced pluripotent stem cellEye ProteinsMolecular BiologyGenetics (clinical)MutationOxadiazolesRetinal pigment epitheliumIntracellular Signaling Peptides and ProteinsMembrane ProteinsRetinalCell DifferentiationEpithelial CellsGeneral MedicineArticlesFibroblastsmedicine.diseaseCellular Reprogramming3. Good healthAtalurenCell biologyProtein Transportmedicine.anatomical_structurePhenotypechemistryProtein BiosynthesisMutationHuman molecular genetics
researchProduct

The prognostic value of biological markers in paediatric Hodgkin lymphoma

2015

Abstract Background Many biological and inflammatory markers have been proposed as having a prognostic value at diagnosis of Hodgkin lymphoma (HL), but very few have been validated in paediatric patients. We explored the significance of these markers in a large population of 769 affected children. Patients and methods By using the database of patients enrolled in A.I.E.O.P. (Associazione Italiana di Emato-Oncologia Pediatrica) trial LH2004 for paediatric HL, we identified 769 consecutive patients treated with curative intent from 1st June 2004 to 1st April 2014 with ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine), or hybrid COPP/ABV (cyclophosphamide, vincristine, prednisone, pr…

MaleOncologyCancer ResearchPathologyTime FactorsDatabases Factualmedicine.medical_treatmenthodgkin lymphoma; paediatric; prognostic factorHodgkin lymphoma; Paediatric; Prognostic factor; Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers Tumor; Child; Child Preschool; Databases Factual; Disease Progression; Disease-Free Survival; Female; Ferritins; Hodgkin Disease; Humans; Infant; Infant Newborn; Italy; Kaplan-Meier Estimate; Leukocyte Count; Male; Multivariate Analysis; Neoplasm Staging; Platelet Count; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Blood Platelets; EosinophilsKaplan-Meier EstimateProcarbazineLeukocyte Countchemistry.chemical_compound0302 clinical medicineRisk FactorsPrednisoneAntineoplastic Combined Chemotherapy ProtocolsChildPrognostic factorTumorAge FactorsHodgkin DiseaseVinblastineTreatment OutcomeSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAItalyOncologyPaediatricChild Preschool030220 oncology & carcinogenesisDisease ProgressionFemalemedicine.drugBlood Plateletsmedicine.medical_specialtyVincristineAdolescentDacarbazineBleomycinDisease-Free SurvivalDatabases03 medical and health sciencesPredictive Value of TestsInternal medicineBiomarkers TumormedicineHumansPreschoolFactualNeoplasm StagingProportional Hazards ModelsRetrospective StudiesChemotherapyPlatelet Countbusiness.industryInfant NewbornInfantNewbornEosinophilschemistryABVDFerritinsMultivariate AnalysisbusinessBiomarkersHodgkin lymphoma030215 immunologyEuropean Journal of Cancer
researchProduct

Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters

2016

Purpose To assess an intensified treatment in the context of clinical and biologic risk factors in metastatic medulloblastoma. Patients and Methods Patients (4 to 21 years old, diagnosed between 2001 and 2007) received induction chemotherapy, dose-escalated hyperfractionated craniospinal radiotherapy, and maintenance chemotherapy. Subgroup status and other biologic parameters were assessed. Results In 123 eligible patients (median age, 8.2 years old; median follow-up, 5.38 years), 5-year event-free survival (EFS) and overall survival (OS) were 62% (95% CI, 52 to 72) and 74% (95% CI, 66 to 82), respectively. OS was superior compared with the precedent HIT ’91 trial. The 5-year EFS and OS wer…

MaleOncologyCancer Researchmedicine.medical_specialtyAdolescentPopulationMedizinMaintenance ChemotherapyAnaplastic MedulloblastomaYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsGermanyInternal medicineAntineoplastic Combined Chemotherapy ProtocolsHumansMedicineProspective StudiesNeoplasm MetastasisCerebellar NeoplasmsChildeducationSurvival rateMedulloblastomaeducation.field_of_studybusiness.industryHazard ratioInduction chemotherapyPrognosismedicine.diseaseCombined Modality TherapySurgerySurvival RateRegimenExact testOncologyAustriaChild Preschool030220 oncology & carcinogenesisFemaleCranial IrradiationNeoplasm Recurrence LocalbusinessSwitzerland030217 neurology & neurosurgeryMedulloblastomaJournal of Clinical Oncology
researchProduct

Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy

2008

To investigate the utility of postoperative chemotherapy in delaying radiotherapy and to identify prognostic factors in early childhood medulloblastoma, we studied children younger than 3 years of age registered to the HIT-SKK'87 (Therapieprotokoll für Säuglinge und Kleinkinder mit Hirntumoren [Brain Tumor Radiotherapy for Infants and Toddlers with Medulloblastoma] 1987) trial who received systemic interval chemotherapy until craniospinal radiotherapy was applied at 3 years of age or at relapse, from 1987 to 1993. Children with postoperative residual tumor or metastatic disease received systemic induction chemotherapy prior to interval chemotherapy. Twenty-nine children were eligible for an…

MaleOncologyCancer Researchmedicine.medical_specialtymedicine.medical_treatmentClinical InvestigationsBrain tumorAntineoplastic AgentsPilot ProjectsDisease-Free SurvivalInternal medicineHumansMedicineProgression-free survivalCerebellar NeoplasmsSurvival rateMedulloblastomaChemotherapybusiness.industryInfantInduction chemotherapyPrognosismedicine.diseaseCombined Modality TherapyChemotherapy regimenSurgerySurvival RateRadiation therapyTreatment OutcomeOncologyChild PreschoolFemaleNeurology (clinical)Cranial IrradiationNeoplasm Recurrence LocalbusinessMedulloblastomaNeuro-Oncology
researchProduct

Second-Line Chemotherapy in Advanced Bladder Cancer

2000

MaleOncologyCarcinoma Transitional Cellmedicine.medical_specialtyClinical Trials Phase I as Topicbusiness.industryUrologyMiddle AgedGenes p53VinblastineSecond line chemotherapyClinical Trials Phase II as TopicMethotrexateUrinary Bladder NeoplasmsDoxorubicinInternal medicineAntineoplastic Combined Chemotherapy ProtocolsAdvanced bladder cancerHumansMedicineFemaleCisplatinbusinessAgedUrologia Internationalis
researchProduct

Searching for Gene Expression Differences in Primary Fibroblasts Between Patients with One and Two Neoplasms in Childhood

2012

Genetic factors are important for developing primary and subsequent malignancies in children. This study investigated the role of genetic factors involved in DNA-repair. Designed as a feasibility study, it addressed the possibility of obtaining samples for genetic analyses from former patients through the German Childhood Cancer Registry. Testing feasibility was as important as the biological question itself. We analyzed the expression of DNA-repair genes in untreated primary fibroblasts of 20 individuals with a second neoplasm compared to 20 matched single neoplasm cases using customized cDNA microarrays (1344 gene sequences, about 800 genes). Matching was by first neoplasm, age, and year …

MaleOncologymedicine.medical_specialtyAdolescentDNA RepairNeoplasmsInternal medicineGene expressionmedicineHumansNeoplasmChildGeneCells CulturedRegulation of gene expressionChildhood Cancer Registrybusiness.industryGene Expression ProfilingInfant NewbornInfantHematologyFibroblastsmedicine.diseaseCancer registryGene Expression Regulation NeoplasticGene expression profilingChildhood NeoplasmOncologyChild PreschoolPediatrics Perinatology and Child HealthImmunologyFemalebusinessPediatric Hematology and Oncology
researchProduct

Prognostic relevance of CCN3 in Ewing sarcoma

2009

Ewing sarcoma is a highly aggressive malignant bone tumor occurring preferentially in children and young adults. At present, only clinical features, such as patient age, presence of clinically evident metastases at diagnosis, and poor response to neoadjuvant chemotherapy, are widely accepted as prognostic indicators in Ewing sarcoma. In this study, we assessed the prognostic value of CCN3 (Nov), a matricellular protein that play crucial roles in bone formation. Polyclonal antibodies directed against each of the different CCN3 modules were used to identify variant CCN3 proteins in tumors and to draw potential relationships between the expression of these variants and the outcome of patients …

MaleOncologymedicine.medical_specialtyPathologyAdolescentTumor suppressor genemedicine.medical_treatmentBlotting WesternGene ExpressionBone NeoplasmsKaplan-Meier EstimateSarcoma EwingPathology and Forensic MedicineNephroblastoma Overexpressed ProteinVon Willebrand factorInternal medicineBiomarkers TumormedicineHumansChildOligonucleotide Array Sequence AnalysisChemotherapyintegumentary systembiologybusiness.industryMatricellular proteinCancerAnatomical pathologyPrognosismedicine.diseaseImmunohistochemistryRadiation therapybiology.proteinFemaleSarcomabusinessHuman Pathology
researchProduct

Studies on vinblastine-induced autophagocytosis in mouse liver

1980

The origin of the membranes of autophagic vacuoles (AV) and acquisition of acid phosphatase into AV's were studied in vinblastine-induced autophagocytosis (VBL, 50 mg/kg, i.p.) in mouse hepatocytes. Using unbuffered OsO4, very intense staining was observed in the outer cisternae of the Golgi apparatus and also frequently in the cavity between the double membranes obviously destined to form AV's as well as in the cavity between the double membranes of newly formed AV's. There may occur a transformation process in the membranes limiting an AV analogous to that observed at the Golgi cisternae. The transformation of the outer AV membrane occurs independently of fusion with lysosomes. Inosine di…

MaleOsmium TetroxideAcid PhosphataseVacuoleVinblastineMicesymbols.namesakeAutophagyAnimalsbiologyHistocytochemistryEndoplasmic reticulumAcid phosphataseIntracellular MembranesGeneral MedicineGolgi apparatusCisternaPhosphoric Monoester HydrolasesAcid Anhydride HydrolasesCell biologyMicroscopy ElectronMembraneLiverBiochemistryVacuolesbiology.proteinGolgi cisternaCytochemistrysymbolsAnatomyLysosomesGeneral Agricultural and Biological SciencesHistochemistry
researchProduct

Oral administration of pharmacological doses of Vitamins C and E reduces reproductive fitness and impairs the ovarian and uterine functions of female…

2002

This study aims to ascertain whether oral administration of pharmacological doses of Vitamins C and E has any detrimental effect on reproductive fitness of female mice. We fed hybrid female mice from the first day of weaning a standard diet supplemented or not supplemented with pharmacological doses of Vitamins C and E. At the age of 28 weeks, we individually caged females with a male for the rest of their reproductive life. We performed a series of mating experiments to ascertain the number of oocytes ovulated and the potential for embryo development in vitro to the blastocyst stage and in vivo to Day 12 of gestation. The antioxidant diet decreased the frequency of litters, litter size, to…

MaleOvulationLitter (animal)medicine.medical_specialtyLitter SizeOffspringmedia_common.quotation_subjectUterusPhysiologyGestational AgeAscorbic AcidFertilization in VitroWeaningBiologyAntioxidantsEmbryonic and Fetal DevelopmentMiceFood AnimalsOral administrationInternal medicinemedicineAnimalsVitamin EWeaningSmall AnimalsOvulationmedia_commonFetusEquineReproductionBody WeightOvaryUterusMice Inbred C57BLBlastocystEndocrinologymedicine.anatomical_structureDietary SupplementsMice Inbred CBAOocytesGestationFemaleAnimal Science and ZoologyTheriogenology
researchProduct

Ameloblastic fibro-odontoma: a case report.

2009

Made available in DSpace on 2013-08-12T17:53:48Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-12-01 Made available in DSpace on 2013-08-12T17:53:48Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-12-01 Made available in DSpace on 2013-08-12T17:53:48Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-12-01 Made available in DSpace on 2013-09-30T18:34:03Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-12-01 Made available in DSpace on 2013-08-12T17:53:48Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-12-01 Made available in DSpace on 2013-09-30T18:34:03Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-12-01 Made available in DSpace on 2013-09-30T18:34:…

MalePanoramic radiographOdontogenic tumorsmedicine.medical_treatmentDentistryFibromaLesionMandibular second molarOdontomaOdontogenic-Tumorsstomatognathic systemDentistry Oral Surgery & MedicinemedicineHumansfibro-odontomaChildGeneral Dentistrybusiness.industryAmeloblastic Fibro-OdontomaMandibleameloblasticOdontomaOdontogenic tumormedicine.disease:CIENCIAS MÉDICAS [UNESCO]CurettageMandibular NeoplasmsOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASLesionsSurgerymedicine.symptombusinessodontomaMedicina oral, patologia oral y cirugia bucal
researchProduct